Bionoid Pharma (Bionoid Pharma) Market Cap : $13.50 Mil (As of May. 21, 2024)

Bionoid Pharma Market Cap Chart

Bionoid Pharma Quarterly Data
	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Market Cap	Get a 7-Day Free Trial												12.02	7.13	13.30	22.02	20.50

Competitive Comparison of Bionoid Pharma's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Bionoid Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionoid Pharma's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bionoid Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where Bionoid Pharma's Market Cap falls into.

Bionoid Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Bionoid Pharma's Market Cap for the fiscal year that ended in Dec. 2010 is calculated as

Bionoid Pharma's Market Cap for the quarter that ended in Mar. 2011 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionoid Pharma  (OTCPK:BINP) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Bionoid Pharma Market Cap Related Terms

Thank you for viewing the detailed overview of Bionoid Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionoid Pharma (Bionoid Pharma) Business Description